Results:
The combination displayed a synergistic anti-cancer effect through promoting the cellular uptake of CUR on different lung cancer cells. Hoechst H33258 staining and FACS assay indicated that the combination of PSII and CUR induced cell cycle arrest and apoptosis. Western blot and cytokine antibody microarray suggested that the combination activated death receptors such as DR6, CD40/CD40L, FasL and TNF-α to induce cancer cells apoptosis, and up-regulated IGFBP-1 leading to inhibition of PI3K/Akt pathway and increase of p21 and p27, which therefore induced a G2 phase arrest in NCI-H446 cells. Meanwhile, the combination suppressed PCNA and NF-κB pathway in 4 kinds of lung cancer cells. They activated the phosphorylation of p38 and JNK, and inhibited PI3K in NCI-H460 and NCI-H446 cells, enhanced the phosphorylation of JNK in NCI-H1299 cells, and increased the phosphorylation of p38 and ERK, and suppressed PI3K in NCI-H520 cells.
Conclusions: PSII combined with CUR had a synergistic anti-cancer effect on lung cancer cells. These findings provided a rationale for using the combination of curcumin and PSII in the treatment of lung cancer in future. apoptosis 10 and so on. However, poor oral bioavailability, glucuronide and sulphate conjugate in plasma account for its poor systemic bioavailability.
11
Interestingly in our previous research, CUR not only alleviated the toxicity and gastric stimulus induced by RPS, 12 but also improved the quality life of mice bearing tumour cells and enhanced their anticancer effect. 13, 14 With the widely application of complex mixtures in clinic, the aim of this study was to investigate the synergistic anticancer effects of PSII and CUR in lung cancer cell lines. Taken together, these findings would provide the foundation for the use of CUR and RPS in future.
| MATERIAL S AND ME THODS

| Reagents
Paris Saponin II (PSII) was provided from National Institute for the Control of Pharmaceutical and Biological Products (purity>91.4%).
Curcumin (CUR) was purchased from Zhongda Co. (China) (90% purity). The other reagents were commercially available and of analytic purity.
| Cell culture
The normal human pulmonary epithelial cell (BEAS-2B) and human lung cancer cells (NCI-H1299, NCI-H460, NCI-H520 and NCI-H446 as adenocarcinoma, large cell carcinoma, squamous carcinoma and SCLC, respectively) were acquired from Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (Shanghai, China).
These cells were cultured in RPMI-1640 medium with 10% foetal bovine serum (Thermo, China) and 1% penicillin-streptomycin (Solarbio Science & Technology Co., Beijing, China) at 37°C in a humidified atmosphere (5% CO 2 ).
| Cell proliferation assays
Cell viability was determined by a colorimetric assay using MTT 
| Cell uptake of CUR
The cells were treated with CUR or the combination of PSII and CUR for 24 hour. The cells were washed in phosphate buffered saline (PBS) thrice and lysed with 1% Triton X-100 for 30 minutes.
The cellular uptake of CUR was measured by fluorescence spectrophotometer (λ excitation = 425 nm, λ emission = 515 nm) (BioTek Instruments, Inc. USA).
| Cell uptake of PSII
The cells were treated with PSII or the combination of PSII and CUR for 24 hour. The cells were washed in PBS thrice and lysed with 1% Triton X-100 for 30 minutes. The solution was deproteinated by adding 100 μL of acetonitrile and 100 μL of methanol followed by vortex mixing for 1 min, ice-cooling and centrifugation (10 000 rpm, 10 minutes, 4°C). The supernatant was then transferred to a HPLC vial and volatilized to dryness with nitrogen prior to analysis. 
| Median-effect analysis
| Hoechst H33258 Staining
The cells were treated with PSII and CUR for 24 hour. The cells were washed in PBS thrice and then fixed in 100% ice-cold methyl alcohol for 10 minutes. After treatment, the cells were washed in PBS thrice and their nuclei were stained with Hoechst H33258 (1 μg/mL) (Solarbio Science & Technology Co., China) for 15 minutes and examined by fluorescence microscopy.
| FACS analysis
The cells were seeded at a density of 3 × 10 
| Western blot analyses
The harvested cells were washed by PBS and lysed with protein 
| Cytokine antibody microarray
The RayBio ® Custom Cytokines Antibody Array kit was purchased from RayBio (RayBio, Shanghai, China) and used according to the manufacturer's instructions. Briefly, total proteins from lung cancer cells were isolated using RayBio ® Cell Lysis Buffer Different letters meant significant differences between 2 groups (P < .05).
corrected mean fluorescence intensities of the pixels within the spot ellipse.
| Statistical analysis
Statistical evaluation was conducted by using the SPSS 17.0 for 
| Combination of PSII and CUR promoted the cellular uptake of CUR and PSII
The cellular uptakes of CUR and PSII in lung cancer cells influenced their anti-tumour activity. As shown in Figure 3 , combination of PSII and CUR promoted singular cellular uptake of CUR and PSII in cancer cells. Meanwhile, the cellular uptake of CUR and PSII in SCLC (NCI-H446) was more sensitive than that in other cells.
| The synergistic anti-cancer effect of PSII and CUR on nucleus morphological changes
In order to further study the synergic anti-cancer effect of PSII and CUR, the morphological changes in 4 lung cancer cells were detected by Hoechst 33258 staining. As shown in Figure 4 , the viable cells exhibited bright blue, while the apoptotic cells showed deep white. The red arrows indicated chromatin condensation, while yellow arrows represented nucleus fragmentation. Compared with the control group, PSII and CUR alone increased the number of the chromatin compaction ( Figure 4B,C) . Meanwhile, the combination of PSII and CUR induced more evident apoptosis characteristics, including nuclear fragmentation and chromatin compaction of apoptotic appearance ( Figure 4D ). It indicated that the combination of PSII and CUR was more effective in pro-apoptosis than any monomer alone.
| The synergistic anti-cancer effect of PSII and CUR on cell apoptosis
To further characterize the synergistic anti-cancer effect of PSII and CUR, Annexin-V FITC/PI double staining was used to confirm this pro-apoptotic phenomenon. As shown in Figure 5 Therefore, the combination of PSII and CUR was more effective on pro-apoptosis than any agent alone.
| The combination of PSII and CUR induced apoptosis via PI3K/AKT, MAPK and NF-κB pathways
In order to understand the potential molecular mechanisms of PSII and CUR, several related pathways including phosphatidyl inositol 3 kinase (PI3K)/AKT, MAPK and nuclear factor-kB (NF-kB) signals were tested. As Figure 6 displayed, the expression of proliferating cell nuclear antigen (PCNA), p-PI3K and NF-κB was decreased and pro caspase 3 was increased in PSII-and CUR-treated lung cancer cells ( Figure 6A were accumulated at G2-phase in NCI-H446 cells.
| Screening of the content of differential cytokines after the combination of PSII-and CURtreated NCI-H446 cells
In order to understand the combination effects of PSII and CUR on cell cycle and apoptosis in lung cancer cells, cytokine analyses were detected in the sensitive cells (NCI-H446). As shown in Table 3 
| D ISCUSS I ON
Rhizoma paridis saponins (RPS) played a good anti-tumour role in many clinical applications. Combination of RPS and CUR not only alleviated the toxicity and gastric stimulus induced by RPS, 12 but also improved the quality life of mice bearing tumour cells and enhanced their anti-cancer effect. 13, 14 In our previous research, PSII (formosanin C) as one of the main effective compounds in RPS 15 was absorbed in rat plasma after oral administration of RPS. 16 Meanwhile, the anti-tumour effect of PSII has been observed in several cultural cells and animal systems through inducing apoptosis, 2 promoting S phase arrest 3 and suppressing NF-κB signalling. 4 It was reported that CUR as a multi-target agent enhanced the efficacy of some chemotherapy drugs by improving their pharmacokinetics 9 and inducing apoptosis. 10, 17 In addition, poor oral bioavailability of PSII 18 and CUR 11 alone promoted the application of their combination in clinic.
This research was to investigate the synergistic anti-cancer effects of PSII and CUR in lung cancer cell lines.
The present results demonstrated that PSII and CUR had synergic anti-cancer effects on lung cancer cells (Figures 1 and 2 ). As our previous report, CUR promoted the absorption of RPS and thereby increased its anti-tumour effect. 13, 14 In this experiment, it also proved that the main compound of RPS, PSII combined with 
The biomarkers in one color shading indicated that they acted in the same pathway TA B L E 3 Representative apoptotic biomarkers in NCI-H446 cells after drug treatment antibody microarray analyses in NCI-H446 cancer cells were carried out. The main pathways involved in the cell apoptosis were the extrinsic death receptor pathway and intrinsic mitochondria pathway. 21 According to the cytokine antibody microarray analyses in NCI-H446 cancer cells, the combination of PSII and CUR mainly induced extrinsic death receptor pathway involved in the programmed cell death (Table 3) . Combination treatment activated the death receptors such as TNF-α, FasL, DR6 and CD40/CD40L to increase the protein expression of caspase 3 and then induced apoptosis ( Figure 8 ).
As we know, the cell cycle was mediated by the activation of cyclin-dependent kinase inhibitors (CKIs), such as p21 and p27. 22 In this research, combination treatment suppressed cell cycle progression in the G2-phase through decreasing p-Akt and therefore up-regulating expression of p27 and p21 in NCI-H446 cells. 23 Furthermore, combination treatment increased the level of IGFBP1 and subsequently inhibited the activity of IGF1 receptor/ PI3K/Akt pathway, 24 which was involved in the cellular differentiation, inflammatory responses, cell cycle arrest and apoptosis in cancer cells. 
